Showing 1–4 of 4 results for author: Shaw, D

Efficient hyperparameter optimization by way of PAC-Bayes bound minimization

Authors: John J. Cherian, Andrew G. Taube, Robert T. McGibbon, Panagiotis Angelikopoulos, Guy Blanc, Michael Snarski, Daniel D. Richman, John L. Klepeis, David E. Shaw

Abstract: Identifying optimal values for a high-dimensional set of hyperparameters is a problem that has received growing attention given its importance to large-scale machine learning applications such as neural architecture search. Recently developed optimization methods can be used to select thousands or even millions of hyperparameters. Such methods often yield overfit models, however, leading to poor p… ▽ More Identifying optimal values for a high-dimensional set of hyperparameters is a problem that has received growing attention given its importance to large-scale machine learning applications such as neural architecture search. Recently developed optimization methods can be used to select thousands or even millions of hyperparameters. Such methods often yield overfit models, however, leading to poor performance on unseen data. We argue that this overfitting results from using the standard hyperparameter optimization objective function. Here we present an alternative objective that is equivalent to a Probably Approximately Correct-Bayes (PAC-Bayes) bound on the expected out-of-sample error. We then devise an efficient gradient-based algorithm to minimize this objective; the proposed method has asymptotic space and time complexity equal to or better than other gradient-based hyperparameter optimization methods. We show that this new method significantly reduces out-of-sample error when applied to hyperparameter optimization problems known to be prone to overfitting. △ Less

Submitted 14 August, 2020; originally announced August 2020.

A deep-learning view of chemical space designed to facilitate drug discovery

Authors: Paul Maragakis, Hunter Nisonoff, Brian Cole, David E. Shaw

Abstract: Drug discovery projects entail cycles of design, synthesis, and testing that yield a series of chemically related small molecules whose properties, such as binding affinity to a given target protein, are progressively tailored to a particular drug discovery goal. The use of deep learning technologies could augment the typical practice of using human intuition in the design cycle, and thereby exped… ▽ More Drug discovery projects entail cycles of design, synthesis, and testing that yield a series of chemically related small molecules whose properties, such as binding affinity to a given target protein, are progressively tailored to a particular drug discovery goal. The use of deep learning technologies could augment the typical practice of using human intuition in the design cycle, and thereby expedite drug discovery projects. Here we present DESMILES, a deep neural network model that advances the state of the art in machine learning approaches to molecular design. We applied DESMILES to a previously published benchmark that assesses the ability of a method to modify input molecules to inhibit the dopamine receptor D2, and DESMILES yielded a 77% lower failure rate compared to state-of-the-art models. To explain the ability of DESMILES to hone molecular properties, we visualize a layer of the DESMILES network, and further demonstrate this ability by using DESMILES to tailor the same molecules used in the D2 benchmark test to dock more potently against seven different receptors. △ Less

Submitted 7 February, 2020; originally announced February 2020.

A New SVDD-Based Multivariate Non-parametric Process Capability Index

Authors: Deovrat Kakde, Arin Chaudhuri, Diana Shaw

Abstract: Process capability index (PCI) is a commonly used statistic to measure ability of a process to operate within the given specifications or to produce products which meet the required quality specifications. PCI can be univariate or multivariate depending upon the number of process specifications or quality characteristics of interest. Most PCIs make distributional assumptions which are often unreal… ▽ More Process capability index (PCI) is a commonly used statistic to measure ability of a process to operate within the given specifications or to produce products which meet the required quality specifications. PCI can be univariate or multivariate depending upon the number of process specifications or quality characteristics of interest. Most PCIs make distributional assumptions which are often unrealistic in practice. This paper proposes a new multivariate non-parametric process capability index. This index can be used when distribution of the process or quality parameters is either unknown or does not follow commonly used distributions such as multivariate normal. △ Less

Submitted 13 November, 2018; originally announced November 2018.

Survival analysis of DNA mutation motifs with penalized proportional hazards

Authors: Jean Feng, David A. Shaw, Vladimir N. Minin, Noah Simon, Frederick A. Matsen IV

Abstract: Antibodies, an essential part of our immune system, develop through an intricate process to bind a wide array of pathogens. This process involves randomly mutating DNA sequences encoding these antibodies to find variants with improved binding, though mutations are not distributed uniformly across sequence sites. Immunologists observe this nonuniformity to be consistent with "mutation motifs", whic… ▽ More Antibodies, an essential part of our immune system, develop through an intricate process to bind a wide array of pathogens. This process involves randomly mutating DNA sequences encoding these antibodies to find variants with improved binding, though mutations are not distributed uniformly across sequence sites. Immunologists observe this nonuniformity to be consistent with "mutation motifs", which are short DNA subsequences that affect how likely a given site is to experience a mutation. Quantifying the effect of motifs on mutation rates is challenging: a large number of possible motifs makes this statistical problem high dimensional, while the unobserved history of the mutation process leads to a nontrivial missing data problem. We introduce an $\ell_1$-penalized proportional hazards model to infer mutation motifs and their effects. In order to estimate model parameters, our method uses a Monte Carlo EM algorithm to marginalize over the unknown ordering of mutations. We show that our method performs better on simulated data compared to current methods and leads to more parsimonious models. The application of proportional hazards to mutation processes is, to our knowledge, novel and formalizes the current methods in a statistical framework that can be easily extended to analyze the effect of other biological features on mutation rates. △ Less

Submitted 21 September, 2018; v1 submitted 10 November, 2017; originally announced November 2017.